FDA approves Endologix's PowerFit extensions to improve stent placement
This article was originally published in Clinica
Endologix's PowerFit aortic extensions have been approved by the US FDA, via a premarket approval (PMA) supplement. The extensions are designed to allow the precise placement of devices such as stents during the repair of abdominal aortic aneurysms. The PowerFit devices, which are visible under fluoroscopy, will be available in a range of sizes, and can be used with Endologix's existing products, including Powerlink bifurcated stents and the IntuiTrak endovascular system. The Irvine, California firm plans a limited launch of the products during the third quarter, followed by full US release in the fourth quarter.